Webinars
Nov 14, 2019
6:00 AM–7:00 AM (EDT)
Online
Webinar
Duration: 1hrs

As the digital PCR technology evolves and becomes more accessible and affordable, the transition from qPCR and adoption of dPCR will hopefully no longer remain a challenge. Experts share insights in an upcoming webinar about the fully integrated, rapid, and highly flexible digital PCR portfolio from QIAGEN. Join us on November 14 to hear from our two speakers and for a live Q&A session.

Nov 14, 2019
9:00 AM–10:00 AM (EDT)
Online
Webinar
Duration: 1hrs

As the digital PCR technology evolves and becomes more accessible and affordable, the transition from qPCR and adoption of dPCR will hopefully no longer remain a challenge. Experts share insights in an upcoming webinar about the fully integrated, rapid, and highly flexible digital PCR portfolio from QIAGEN. Join us on November 14 to hear from our two speakers and for a live Q&A session.

Nov 14, 2019
1:00 PM–2:00 PM (EDT)
Online
Webinar
Duration: 1hrs

As the digital PCR technology evolves and becomes more accessible and affordable, the transition from qPCR and adoption of dPCR will hopefully no longer remain a challenge. Experts share insights in an upcoming webinar about the fully integrated, rapid, and highly flexible digital PCR portfolio from QIAGEN. Join us on November 14 to hear from our two speakers and for a live Q&A session.

Nov 19, 2019
9:00 AM–10:00 AM (EST)
Online
Webinar
Duration: 1hrs
Join us for a discussion on how researchers are using QIAseq FastSelect technology with fragmented and high-quality RNA for both short and long-read RNA-seq analysis. 
Nov 19, 2019
11:00 AM–12:00 PM (EST)
Online
Webinar
Duration: 1hrs
La presente investigación muestra las ventajas de extraer DNA de tejido cartilaginoso de arcos costales y epífisis de huesos largos si se compara con la extracción de DNA de huesos procedentes de cadáveres putrefactos.
Nov 19, 2019
4:00 PM–5:00 PM (EST)
Online
Webinar
Duration: 1hrs
Join us for a discussion on how researchers are using QIAseq FastSelect technology with fragmented and high-quality RNA for both short and long-read RNA-seq analysis. 
Nov 20, 2019
9:00 AM–10:00 AM (EST)
Online
Webinar
Duration: 1hrs
This webinar will describe QIAGEN’s approach to kit development, and the support options available around RT- and PCR-enzymes, master mix formulations and assay development and supply.
Nov 20, 2019
1:00 PM–2:00 PM (EST)
Online
Webinar
Duration: 1hrs
In this presentation, Dr. Ben Chaffey and Dr. Dave Hout will firstly introduce the QIAGEN therascreen® FGFR RGQ RT-PCR Kit, which was recently approved by the FDA as the companion diagnostic test to guide prescription of BALVERSATM, a novel FGFR inhibitor, in cases of urothelial cancer.  
Nov 20, 2019
1:00 PM–2:00 PM (EST)
Online
Webinar
Duration: 1hrs
This webinar will describe QIAGEN’s approach to kit development, and the support options available around RT- and PCR-enzymes, master mix formulations and assay development and supply.
Nov 21, 2019
2:00 AM–3:00 AM (EST)
Online
Webinar
Duration: 1hrs
This webinar will describe QIAGEN’s approach to kit development, and the support options available around RT- and PCR-enzymes, master mix formulations and assay development and supply.
Back to top